In the field of ophthalmology, numerous diseases are closely associated with vascular abnormalities. For instance, diabetic retinopathy (DR) and age-related macular degeneration (AMD), which stand as major causes of visual impairment, stem from aberrant neovascularization within the retinal or choroidal regions, respectively. The foundation of therapeutic approaches in ophthalmology often involves interference with receptor signaling pathways. A widely adopted strategy entails the inhibition of signaling pathways that play a pivotal role in angiogenesis or vasculogenesis within the eyes. BsAbs offer a compelling solution, as they have the capability to simultaneously target two distinct pathways or intervene at two distinct points within the same pathway. Consequently, BsAbs stand as a formidable class of therapeutic agents, poised to lead the next generation of pharmaceutical innovations in the treatment of ocular diseases.
Creative Biolabs provides our customers with top-tier BsAbs developed on the basis of our cutting-edge and innovative technology platforms. Our accomplished team of researchers is well-versed in BsAbs design, and equipped to formulate tailored BsAbs and innovative strategies to elevate the caliber of your scientific and clinical endeavors within the realm of ophthalmology. Please feel free to reach out to us for further information or inquiries.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY
SERVICES
PRODUCTS
PLATFORMS
